News & Videos - BIOGEN IDEC

You are currently viewing all stock exchange news of the financial instrument BIOGEN IDEC regarding all markets in all languages.

BIOGEN IDEC > News PR Newswire published a news.

Cipla receives final approval for generic version of Biogen IDEC Inc.'s Tecfidera® (Dimethyl Fumarate DR Capsules 120mg, 240mg and 120mg/240mg Starter Pack) • • PR Newswire • Stocks

Cipla receives final approval for generic version of Biogen IDEC Inc.'s Tecfidera® (Dimethyl Fumarate DR Capsules 120mg, 240mg and 120mg/240mg Starter Pack) PR Newswire MUMBAI, India, Sept. 28, 2020 MUMBAI, India , Sept. 28, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Dimethyl Fumarate DR Capsules 120mg, 240mg and 120mg/240mg Starter...

Thank you